

‘The HemOnc Pulse’ Live: Unanswered Questions in T-Cell Lymphoma
May 30, 2024
Experts at 'The HemOnc Pulse' Live discuss uncertainties in T-cell lymphoma management including transplant timing, novel agents for relapsed/refractory cases, potential of JAK inhibitors, exploring different CAR T constructs, and benefits of sequencing for actionable mutations.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Debate on Transplant Role in T-Cell Lymphoma Treatment
01:43 • 11min
Novel Agents in Relapsed/Refractory T-Cell Lymphoma
12:22 • 10min
Exploring JAK Inhibitors for T-Cell Lymphoma
22:50 • 4min
Exploring Different CAR T Constructs in T-Cell Lymphoma
26:54 • 3min
Challenges and Potential Benefits of Sequencing in T-Cell Lymphomas
29:55 • 2min